MicroRNA-126 promotes proliferation, migration, invasion and endothelial differentiation while inhibits apoptosis and osteogenic differentiation of bone marrow-derived mesenchymal stem cells

References

• Jia Z, Wang S, Liang Y, et al. Combination of kartogenin and transforming growth factor-beta3 supports synovial fluid-derived mesenchymal stem cell-based cartilage regeneration. Am J Transl Res. 2019;11:2056–2069.
   PubMed Web of Science ®Google Scholar
• Lubis AMT, Panjaitan T, Hoo C. Autologous mesenchymal stem cell application for cartilage defect in recurrent patellar dislocation: a case report. Int J Surg Case Rep. 2019;55:183–186.
   PubMed Web of Science ®Google Scholar
• Gopal K, Amirhamed HA, Kamarul T. Advances of human bone marrow-derived mesenchymal stem cells in the treatment of cartilage defects: a systematic review. Exp Biol Med (Maywood). 2014;239:663–669.
   PubMed Web of Science ®Google Scholar
• Zhao R, Li Y, Lin Z, et al. miR-199b-5p modulates BMSC osteogenesis via suppressing GSK-3beta/beta-catenin signaling pathway. Biochem Biophys Res Commun. 2016;477:749–754.
   PubMed Web of Science ®Google Scholar
• Mahboudi H, Kazemi B, Soleimani M, et al. Enhanced chondrogenesis of human bone marrow mesenchymal stem cell (BMSC) on nanofiber-based polyethersulfone (PES) scaffold. Gene. 2018;643:98–106.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yi C, Zheng Y, et al. Enhancement of fat graft survival by bone marrow-derived mesenchymal stem cell therapy. Plast Reconstr Surg. 2013;132:1149–1157.
   PubMed Web of Science ®Google Scholar
• Sun X, Luo LH, Feng L, et al. Down-regulation of lncRNA MEG3 promotes endothelial differentiation of bone marrow derived mesenchymal stem cells in repairing erectile dysfunction. Life Sci. 2018;208:246–252.
   PubMed Web of Science ®Google Scholar
• Idriss NK, Sayyed HG, Osama A, et al. Treatment efficiency of different routes of bone marrow-derived mesenchymal stem cell injection in rat liver fibrosis model. Cell Physiol Biochem. 2018;48:2161–2171.
   PubMedGoogle Scholar
• Jahromi GP, Shabanzadeh AP, Hashtjini MM, et al. Bone marrow-derived mesenchymal stem cell and simvastatin treatment leads to improved functional recovery and modified c-Fos expression levels in the brain following ischemic stroke. Iran J Basic Med Sci. 2018;21:1004–1012.
   PubMed Web of Science ®Google Scholar
• Davis AB, Schnabel LV, Gilger BC. Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: a case series. Vet Ophthalmol. 2019;22:674–682.
   PubMed Web of Science ®Google Scholar
• van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018;32:174–187.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–2038.
   PubMed Web of Science ®Google Scholar
• Ishchenko A, Lories RJ. Safety and efficacy of biological disease-modifying antirheumatic drugs in older rheumatoid arthritis patients: staying the distance. Drugs Aging. 2016;33:387–398.
   PubMed Web of Science ®Google Scholar
• Hazlewood GS, Barnabe C, Tomlinson G, et al. Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged cochrane systematic review and network meta-analysis. BMJ. 2016;353:i1777.
   PubMed Web of Science ®Google Scholar
• Putrik P, Ramiro S, Kvien TK, et al. Inequities in access to biologic and synthetic DMARDs across 46 European countries. Ann Rheum Dis. 2014;73:198–206.
   PubMed Web of Science ®Google Scholar
• Liang J, Li X, Zhang H, et al. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol. 2012;31:157–161.
   PubMed Web of Science ®Google Scholar
• Lin S, Gregory RI. MicroRNA biogenesis pathways in cancer. Nat Rev Cancer. 2015;15:321–333.
   PubMed Web of Science ®Google Scholar
• Jiang L, Cao S. Role of microRNA-26a in cartilage injury and chondrocyte proliferation and apoptosis in rheumatoid arthritis rats by regulating expression of CTGF. J Cell Physiol. 2020;235:979–992.
   Web of Science ®Google Scholar
• Qiang J, Lv T, Wu Z, et al. Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-kappaB signaling. Biosci Rep. 2019;39. DOI:https://doi.org/10.1042/BSR20190700.
   Google Scholar
• Huang Z, Xing S, Liu M, et al. MiR-26a-5p enhances cells proliferation, invasion, and apoptosis resistance of fibroblast-like synoviocytes in rheumatoid arthritis by regulating PTEN/PI3K/AKT pathway. Biosci Rep. 2019;39. DOI:https://doi.org/10.1042/BSR20182192.
   Web of Science ®Google Scholar
• Hernandez-Preciado MR, Moran-Moguel MC, Davalos-Rodriguez IP, et al. miRNA-24 gene sequence, DHFR −829C-T genotypes, and methotrexate response in mexican patients with rheumatoid arthritis. Genet Test Mol Biomarkers. 2019;23:223–227.
   PubMed Web of Science ®Google Scholar
• Qu Y, Wu J, Deng JX, et al. MicroRNA-126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3K-AKT signal pathway. Oncotarget. 2016;7:74217–74226.
   PubMedGoogle Scholar
• Paschalaki KE, Zampetaki A, Baker JR, et al. Downregulation of MicroRNA-126 augments DNA damage response in cigarette smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197:665–668.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res. 2010;107:810–817.
   PubMed Web of Science ®Google Scholar
• Gao J, Zhou XL, Kong RN, et al. microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway. Exp Mol Pathol. 2016;100:192–198.
   PubMed Web of Science ®Google Scholar
• Gao J, Kong R, Zhou X, et al. MiRNA-126 expression inhibits IL-23R mediated TNF-alpha or IFN-gamma production in fibroblast-like synoviocytes in a mice model of collagen-induced rheumatoid arthritis. Apoptosis. 2018;23:607–615.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Zhou SH. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. Cardiol J. 2011;18:675–681.
   PubMed Web of Science ®Google Scholar
• Lee KW, Kim DH, Lee JH, et al. The effect of pulsatile flow on bMSC-derived endothelial-like cells in a small-sized artificial vessel made by 3-dimensional bioprinting. Stem Cells Int. 2018;2018:7823830.
   PubMed Web of Science ®Google Scholar
• Zhu G, Pei L, Lin F, et al. Exosomes from human-bone-marrow-derived mesenchymal stem cells protect against renal ischemia/reperfusion injury via transferring miR-199a-3p. J Cell Physiol. 2019;234:23736–23749.
   PubMed Web of Science ®Google Scholar
• Mashimo T, Sato Y, Akita D, et al. Bone marrow-derived mesenchymal stem cells enhance bone marrow regeneration in dental extraction sockets. J Oral Sci. 2019;61:284–293.
   PubMed Web of Science ®Google Scholar
• Yi TG, Cho YK, Lee HJ, et al. A novel Immunomodulatory mechanism dependent on acetylcholine secreted by human bone marrow-derived mesenchymal stem cells. Int J Stem Cells. 2019;12:315–330.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Nishida Y, Takahashi S, et al. Transplantation of autologous bone marrow-derived mesenchymal stem cells under arthroscopic surgery with microfracture versus microfracture alone for articular cartilage lesions in the knee: a multicenter prospective randomized control clinical trial. Regen Ther. 2019;11:106–113.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang H, Yin T, et al. TMEM18 inhibits osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells by inactivating beta-catenin. Exp Cell Res. 2019:111491. DOI:https://doi.org/10.1016/j.yexcr.2019.07.004.
   Google Scholar
• Abdallah BM, Ali EM. 5ʹ-hydroxy auraptene stimulates osteoblast differentiation of bone marrow-derived mesenchymal stem cells via a BMP-dependent mechanism. J Biomed Sci. 2019;26:51.
   PubMed Web of Science ®Google Scholar
• Lamas JR, Mucientes A, Lajas C, et al. Check-control of inflammation displayed by bone marrow mesenchymal stem cells in rheumatoid arthritis patients. Immunotherapy. 2019;11:1107–1116.
   PubMed Web of Science ®Google Scholar
• Lamas JR, Fernandez-Gutierrez B, Mucientes A, et al. RNA sequencing of mesenchymal stem cells reveals a blocking of differentiation and immunomodulatory activities under inflammatory conditions in rheumatoid arthritis patients. Arthritis Res Ther. 2019;21:112.
   PubMed Web of Science ®Google Scholar
• El Qashty RMN, Mohamed NN, Radwan LRS, et al. Effect of bone marrow mesenchymal stem cells on healing of temporomandibular joints in rats with induced rheumatoid arthritis. Eur J Oral Sci. 2018;126:272–281.
   PubMed Web of Science ®Google Scholar
• Ghoryani M, Shariati-Sarabi Z, Tavakkol-Afshari J, et al. Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: a successful clinical trial in Iran. Biomed Pharmacother. 2019;109:1834–1840.
   PubMed Web of Science ®Google Scholar
• Ding W, Li J, Singh J, et al. miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice. Cardiovasc Res. 2015;106:131–142.
   PubMed Web of Science ®Google Scholar
• Minayi N, Alizadeh S, Dargahi H, et al. The effect of miR-210 up-regulation on proliferation and survival of mouse bone marrow derived mesenchymal stem cell. Int J Hematol Oncol Stem Cell Res. 2014;8:15–23.
   PubMedGoogle Scholar
• Zhang F, Jing S, Ren T, et al. MicroRNA-10b promotes the migration of mouse bone marrow-derived mesenchymal stem cells and downregulates the expression of E-cadherin. Mol Med Rep. 2013;8:1084–1088.
   PubMed Web of Science ®Google Scholar
• Lechman ER, Gentner B, Ng SW, et al. miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells. Cancer Cell. 2016;29:214–228.
   PubMed Web of Science ®Google Scholar
• Togliatto G, Dentelli P, Gili M, et al. Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: impact on clinical applications. Int J Obes (Lond). 2016;40:102–111.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zeng S, Quan C, et al. Induction function of miR-126 in survival and proliferation in neural stem cells. Med Sci Monit. 2015;21:3023–3027.
   PubMed Web of Science ®Google Scholar
• Pan Q, Wang Y, Lan Q, et al. Exosomes derived from mesenchymal stem cells ameliorate hypoxia/reoxygenation-injured ECs via transferring MicroRNA-126. Stem Cells Int. 2019;2019:2831756.
   PubMed Web of Science ®Google Scholar
• Zhang W, Wang Y, Kong Y. Exosomes derived from mesenchymal stem cells modulate miR-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting HMGB1. Invest Ophthalmol Vis Sci. 2019;60:294–303.
   PubMed Web of Science ®Google Scholar
• Pitzler L, Auler M, Probst K, et al. miR-126-3p promotes matrix-dependent perivascular cell attachment, migration and intercellular interaction. Stem Cells. 2016;34:1297–1309.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim BG, Ahn JM, et al. Role of PI3K on the regulation of BMP2-induced beta-catenin activation in human bone marrow stem cells. Bone. 2010;46:1522–1532.
   PubMed Web of Science ®Google Scholar
• Li L, Xia Y, Wang Z, et al. Suppression of the PI3K-Akt pathway is involved in the decreased adhesion and migration of bone marrow-derived mesenchymal stem cells from non-obese diabetic mice. Cell Biol Int. 2011;35:961–966.
   PubMed Web of Science ®Google Scholar
• Sheng L, Mao X, Yu Q, et al. Effect of the PI3K/AKT signaling pathway on hypoxia-induced proliferation and differentiation of bone marrow-derived mesenchymal stem cells. Exp Ther Med. 2017;13:55–62.
   PubMed Web of Science ®Google Scholar
• Kim K, Kong SY, Fulciniti M, et al. Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo. Br J Haematol. 2010;149:537–549.
   PubMed Web of Science ®Google Scholar
• Sha Y, Lv Y, Xu Z, et al. MGF E peptide pretreatment improves the proliferation and osteogenic differentiation of BMSCs via MEK-ERK1/2 and PI3K-Akt pathway under severe hypoxia. Life Sci. 2017;189:52–62.
   PubMed Web of Science ®Google Scholar
• Li WM, Yue JN, Guo DQ, et al. MiR-126 promotes endothelial cell apoptosis by targeting PI3K/Akt in rats with lower limb arteriosclerosis obliterans. Eur Rev Med Pharmacol Sci. 2019;23:327–333.
   PubMed Web of Science ®Google Scholar
• Chang L, Liang J, Xia X, et al. miRNA-126 enhances viability, colony formation, and migration of keratinocytes HaCaT cells by regulating PI3 K/AKT signaling pathway. Cell Biol Int. 2019;43:182–191.
   PubMed Web of Science ®Google Scholar
• Shi H, Bi H, Sun X, et al. Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway. Mol Med Rep. 2018;17:4327–4336.
   PubMed Web of Science ®Google Scholar
• Xiang G, Cheng Y. MiR-126-3p inhibits ovarian cancer proliferation and invasion via targeting PLXNB2. Reprod Biol. 2018;18:218–224.
   PubMed Web of Science ®Google Scholar
• Tsumaru S, Masumoto H, Minakata K, et al. Therapeutic angiogenesis by local sustained release of microRNA-126 using poly lactic-co-glycolic acid nanoparticles in murine hindlimb ischemia. J Vasc Surg. 2018;68:1209–1215.
   PubMed Web of Science ®Google Scholar
• Li Y, Li Y, Ge P, et al. MiR-126 regulates the ERK pathway via targeting KRAS to inhibit the glioma cell proliferation and invasion. Mol Neurobiol. 2017;54:137–145.
   PubMed Web of Science ®Google Scholar